Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04326010 · ClinicalTrials.gov registry record
Prospective Clinical Follow-up of the Echo Bi-Metric Microplasty Stem for Total Hip Arthroplasty
A clinical trial, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- 206
- Enrollment target
NCT04326010: Clinical Trial study, sponsored by Zimmer Biomet.
NCT04326010 is a clinical trial that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 206 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04326010 was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- 206 participants
- Enrollment target
Study Summary
The primary objective of this study is to characterize survivorship of the Echo Bi-Metric Microplasty stem in unilateral or bilateral primary total hip arthroplasty at 5 years postoperative.
Primary Outcome
The primary objective of this study is to characterize survivorship of the Echo Bi-Metric Microplasty stem in unilateral or bilateral primary total hip arthroplasty at 5 years postoperative.
Interventions
- DEVICE Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2017-02-20 |
| Est. Completion | 2024-12-04 |
Why NCT04326010 stopped before completion
NCT04326010 is an observational study that tracks outcomes without assigning an intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Surgery is the first listed.
NCT04326010 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04326010 about?
NCT04326010 is a clinical study titled "Prospective Clinical Follow-up of the Echo Bi-Metric Microplasty Stem for Total Hip Arthroplasty". The primary objective of this study is to characterize survivorship of the Echo Bi-Metric Microplasty stem in unilateral or bilateral primary total hip arthroplasty at 5 years postoperative.
What is the current status of trial NCT04326010?
This trial is currently terminated. The enrollment target is 206 participants. The study started on 2017-02-20. Estimated completion is 2024-12-04.
What interventions are being tested in trial NCT04326010?
The interventions under investigation include: Surgery (DEVICE).
Who is sponsoring clinical trial NCT04326010?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03373968 · 206 participants · Phase 2
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
- NCT03550391 · 206 participants · Phase 3
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- NCT04757116 · 206 participants · NA
Post-Market Study to Assess iTind Safety in Comparison to UroLift
- NCT05675865 · 206 participants · NA
Cryoablation for Monomorphic Ventricular Tachycardia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI